AI Article Synopsis
- Few studies focus on how doctors decide on mood stabilizers or antipsychotics for bipolar disorder patients, despite the ongoing use of traditional antidepressants with little evidence of their effectiveness.
- The article highlights pharmacological principles that support the evidence-based approach to using mood stabilizers and antipsychotics.
- It reviews important aspects like choosing the right therapies for ongoing treatment, decision-making strategies when there's only a partial response to treatment, the use of combination therapies, and weighing the benefits and risks when treating bipolar depression.
Article Abstract
Few studies have examined the decision-making process for selecting a mood stabilizer or antipsychotic for patients with bipolar disorder. Despite a lack of evidence regarding their efficacy, conventional unimodal antidepressants continue to be used in bipolar treatment regimens. This article examines pharmacologic principles that can facilitate the evidence-based use of mood stabilizers and antipsychotics in patients with bipolar disorder. Choosing therapies for the maintenance of bipolar disorder, clinical decision making upon observation of a partial response, the use of combination therapies, and benefit/harm considerations when choosing a treatment for bipolar depression will be reviewed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4088/JCP.13095tx2cj | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!